间充质干细胞
慢性疼痛
医学
微泡
干细胞
诱导多能干细胞
生物信息学
病因学
免疫系统
再生医学
小RNA
免疫学
内科学
精神科
病理
胚胎干细胞
生物
生物化学
基因
遗传学
作者
Jinxuan Ren,Na Liu,Na Sun,Kehan Zhang,Lina Yu
出处
期刊:Current stem cell research & therapy
[Bentham Science]
日期:2019-09-12
卷期号:14 (8): 644-653
被引量:25
标识
DOI:10.2174/1574888x14666190912162504
摘要
Chronic pain is a common condition that seriously affects the quality of human life with variable etiology and complicated symptoms; people who suffer from chronic pain may experience anxiety, depression, insomnia, and other harmful emotions. Currently, chronic pain treatments are nonsteroidal anti-inflammatory drugs and opioids; these drugs are demonstrated to be insufficient and cause severe side effects. Therefore, research into new therapeutic strategies for chronic pain is a top priority. In recent years, stem cell transplantation has been demonstrated to be a potent alternative for the treatment of chronic pain. Mesenchymal stem cells (MSCs), a type of pluripotent stem cell, exhibit multi-directional differentiation, promotion of stem cell implantation, and immune regulation; they have also been shown to exert analgesic effects in several chronic pain models. Exosomes produced by MSCs have been demonstrated to relieve painful symptoms with fewer side effects. In this review, we summarize the therapeutic use of MSCs in various chronic pain studies. We also discuss ways to enhance the treatment effect of MSCs. We predict in the future, cell-free therapies for chronic pain will develop from exosomes secreted by MSCs.
科研通智能强力驱动
Strongly Powered by AbleSci AI